ClinicsCompoundsVendorsCompareBlogMethodology

Cartalax — Benefits, Dosage & Where to Buy

Also known as: Ala-Glu-Asp, AED peptide, Khavinson cartilage peptide
Anti-Aging & Longevity7 vendors
$1.83
Lowest $/mg
$3.50
Highest $/mg
7
Products

Research Overview

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) bioregulator targeting cartilage and connective tissue. Part of the Khavinson system, it modulates gene expression in chondrocytes and has been studied for osteoarthritis and age-related cartilage degeneration.

In preclinical studies, Cartalax promoted chondrocyte proliferation and extracellular matrix production, supporting cartilage repair processes.

Key Research Findings

  • Promoted chondrocyte proliferation and matrix production
  • Supported cartilage repair in osteoarthritis models
  • Modulated gene expression in cartilage tissue
  • Part of Khavinson's tissue-specific bioregulatory system

Research Dosage Protocols

Administered in 10-day courses of 10 mg daily, repeated 2-3 times annually.

For research reference only. Not medical advice. Not for human consumption.

Price Comparison (7 products from 7 vendors)

VendorPriceStock
Peptide Crafters
$55.00
$1.83/mg
30mg lyophilized
In Stock
Skye Peptides
$59.00
$2.36/mg
25mg lyophilized
In Stock
Swiss Chems
$61.95
$3.10/mg
20mg vial
In Stock
Core Peptides
$63.00
$3.15/mg
20mg vial
In Stock
Soma Chems
$64.99
$3.25/mg
20mg vial
In Stock
Pure Rawz
$66.92
$3.35/mg
20mg vial
In Stock
BioLongevity Labs
$69.97
$3.50/mg
20mg vial
In Stock

Frequently Asked Questions

What is Cartalax?

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed by Professor Vladimir Khavinson as a bioregulator peptide targeting cartilage tissue. It is designed to modulate chondrocyte activity and support cartilage repair and maintenance. It belongs to the Khavinson bioregulator peptide family alongside compounds like Thymalin, Epithalon, and Pancragen.

What is Cartalax used for in research?

Cartalax is researched for cartilage tissue repair, chondrocyte proliferation, and age-related cartilage degeneration. Studies have examined its effects on gene expression in cartilage cells and its potential role in joint health and osteoarthritis models.

How is Cartalax dosed in research protocols?

Standard Khavinson bioregulator protocols use 10mg daily for 10-day courses, administered 2-3 times per year. Cartalax follows this same protocol pattern. It is typically supplied as a lyophilized powder for subcutaneous injection.

Where can I buy Cartalax for research?

Cartalax is available from multiple research peptide vendors. Price-per-milligram ranges from approximately $1.83 to $3.50 across vendors. Check our price comparison table above for current availability and pricing.

Is Cartalax the same as BPC-157 for joint research?

No. BPC-157 is a 15-amino-acid peptide researched for broad tissue repair including tendons, ligaments, and gut. Cartalax is a 3-amino-acid bioregulator specifically targeting cartilage tissue through gene expression modulation. They have different mechanisms, and BPC-157 has substantially more published research.

Related Compounds